妊娠相关终末期肾病患者的特征与结局
该队列研究基于美国肾脏数据系统纳入2000年1月1日至2020年11月20日183 640例育龄女性新发终末期肾病患者,其中341例主要病因为妊娠相关终末期肾病(平均年龄30.2岁)。与一般美国分娩人群相比,黑人患者占比过高(31.9% vs 16.2%)。校正后,妊娠相关终末期肾病患者的死亡风险与肾小球肾炎或囊性肾病相似(aHR 0.96;95%CI 0.76-1.19),低于糖尿病或高血压(aHR 0.49;95%CI 0.39-0.61)及其他或不明病因(aHR 0.60;95%CI 0.48-0.75);但获得肾移植的机会显著更低:与肾小球肾炎或囊性肾病相比 aSHR 0.51(95%CI 0.43-0.66),与糖尿病或高血压相比 aSHR 0.81(95%CI 0.67-0.98),与其他或不明病因相比 aSHR 0.82(95%CI 0.67-0.99)。这些患者终末期肾病前接受肾脏科照护(aRR 0.47;95%CI 0.40-0.56)及已放置移植物或动静脉内瘘(aRR 0.31;95%CI 0.17-0.57)的比例也更低。作者认为增加照护可及性可能改善这一长期生存潜力高的年轻人群的生活质量和健康结局。
要点
- 妊娠相关终末期肾病患者平均年龄30.2岁,黑人占31.9%,显著高于美国一般分娩人群的16.2%。
- 校正后死亡风险与肾小球肾炎或囊性肾病相似(aHR 0.96;95%CI 0.76-1.19),低于糖尿病或高血压(aHR 0.49;95%CI 0.39-0.61)。
- 获得肾移植的机会显著更低:与肾小球肾炎或囊性肾病相比 aSHR 0.51(95%CI 0.43-0.66)。
- 终末期肾病前接受肾脏科照护(aRR 0.47;95%CI 0.40-0.56)及放置移植物或动静脉内瘘(aRR 0.31;95%CI 0.17-0.57)的比例更低。
- 作者认为增加照护可及性可能改善这一长期生存潜力高的年轻人群的生活质量和健康结局。
适用人群与场景
- 2000年1月1日至2020年11月20日美国肾脏数据系统中新发终末期肾病的183 640例育龄女性,其中341例主要病因为妊娠相关终末期肾病(平均年龄30.2岁)。
研究设计与关键结果
- 研究类型为队列研究,数据来自美国肾脏数据系统及美国疾病控制与预防中心公开的分娩数据,共纳入183 640例育龄女性新发终末期肾病患者,其中341例主要病因为妊娠相关终末期肾病。
- 与一般美国分娩人群相比,妊娠相关终末期肾病患者中黑人占比过高:109例(31.9%)vs 585 268例(16.2%)。
- 校正后死亡风险:与肾小球肾炎或囊性肾病相比 aHR 0.96(95%CI 0.76-1.19);与糖尿病或高血压相比 aHR 0.49(95%CI 0.39-0.61);与其他或不明病因相比 aHR 0.60(95%CI 0.48-0.75)。
- 获得肾移植的机会:与肾小球肾炎或囊性肾病相比 aSHR 0.51(95%CI 0.43-0.66);与糖尿病或高血压相比 aSHR 0.81(95%CI 0.67-0.98);与其他或不明病因相比 aSHR 0.82(95%CI 0.67-0.99)。
- 终末期肾病前接受肾脏科照护的校正相对危险度 aRR 0.47(95%CI 0.40-0.56);已放置移植物或动静脉内瘘的 aRR 0.31(95%CI 0.17-0.57)。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为增加照护可及性可能改善这一长期生存潜力高的年轻人群的生活质量和健康结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The incidence of pregnancy-related acute kidney injury is increasing and is associated with significant maternal morbidity including progression to end-stage kidney disease (ESKD). Little is known about characteristics and long-term outcomes of patients who develop pregnancy-related ESKD.
OBJECTIVES: To examine the characteristics and clinical outcomes of patients with pregnancy-related ESKD and to investigate associations between pre-ESKD nephrology care and outcomes.
DESIGN, SETTING, AND PARTICIPANTS: This was a cohort study of 183 640 reproductive-aged women with incident ESKD between January 1, 2000, and November 20, 2020, from the US Renal Data System and maternal data from births captured in the US Centers for Disease Control and Prevention publicly available natality data. Data were analyzed from December 2022 to June 2023.
EXPOSURE: Pregnancy-related primary cause of ESKD, per International Classification of Diseases, Ninth Revision (ICD-9) and ICD-10 codes reported at ESKD onset by the primary nephrologist on Centers for Medicare and Medicaid Services form 2728.
MAIN OUTCOMES MEASURES: Multivariable Cox proportional hazards and competing risk models were constructed to examine time to (1) mortality, (2) access to kidney transplant (joining the waiting list or receiving a live donor transplant), and (3) receipt of transplant after joining the waitlist.
RESULTS: A total of 341 patients with a pregnancy-related primary cause of ESKD were identified (mean [SD] age 30.2 [7.3]). Compared with the general US birthing population, Black patients were overrepresented among those with pregnancy-related ESKD (109 patients [31.9%] vs 585 268 patients [16.2%]). In adjusted analyses, patients with pregnancy-related ESKD had similar or lower hazards of mortality compared with those with glomerulonephritis or cystic kidney disease (adjusted hazard ratio [aHR], 0.96; 95% CI, 0.76-1.19), diabetes or hypertension (aHR, 0.49; 95% CI, 0.39-0.61), or other or unknown primary causes of ESKD (aHR, 0.60; 95% CI, 0.48-0.75). Despite this, patients with pregnancy-related ESKD had significantly lower access to kidney transplant compared with those with other causes of ESKD, including (1) glomerulonephritis or cystic kidney disease (adjusted subhazard ratio [aSHR], 0.51; 95% CI, 0.43-0.66), (2) diabetes or hypertension (aSHR, 0.81; 95% CI, 0.67-0.98), and (3) other or unkown cause (aSHR, 0.82; 95% CI, 0.67-0.99). Those with pregnancy-related ESKD were less likely to have nephrology care or have a graft or arteriovenous fistula placed before ESKD onset (nephrology care: adjusted relative risk [aRR], 0.47; 95% CI, 0.40-0.56; graft or arteriovenous fistula placed: aRR, 0.31; 95% CI, 0.17-0.57).
CONCLUSION AND RELEVANCE: In this study, those with pregnancy-related ESKD had reduced access to transplant and nephrology care, which could exacerbate existing disparities in a disproportionately Black population. Increased access to care could improve quality of life and health outcomes among these young adults with high potential for long-term survival.
参考来源
- Kucirka LM, Angarita AM, Manuck TA, et al. Characteristics and Outcomes of Patients With Pregnancy-Related End-Stage Kidney Disease. JAMA Netw Open. 2023. PMID: 38064217. doi:10.1001/jamanetworkopen.2023.46314
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。